Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.88% | -14.18% | 4.57% | 14.62% | 17.41% |
| Total Depreciation and Amortization | 2.10% | -17.15% | -33.55% | -47.48% | -40.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.81% | 80.54% | 79.50% | 57.90% | 41.49% |
| Change in Net Operating Assets | 160.25% | 12.31% | 84.08% | -49.09% | -408.41% |
| Cash from Operations | -20.73% | -5.03% | 16.16% | 18.68% | 11.96% |
| Capital Expenditure | -155.88% | 15.41% | 32.38% | 51.74% | 69.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -155.88% | 15.41% | 32.38% | 51.74% | 69.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 53.60% | -- | -- | -- |
| Issuance of Common Stock | -18.83% | 3,306.80% | 2,368.78% | 379.98% | 301.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.18% | 1,277.57% | 1,352.45% | 258.50% | 212.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -210.98% | 136.03% | 139.97% | 141.51% | 139.91% |